Par Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.20 Cr
- Paid Up Capital ₹ 2.14 Cr
- Company Age 42 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.71 M
- Satisfied Charges ₹ 62.37 Cr
- Revenue Growth 55.06%
- Profit Growth 104.06%
- Ebitda 70.36%
- Net Worth 19.04%
- Total Assets 43.05%
About Par Formulations
Par Formulations Private Limited (PFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 September 1982 and has a history of 42 years and four months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Ch Krishnan And Associates Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.20 Cr and a paid-up capital of Rs 2.14 Cr.
The company currently has active open charges totaling ₹1.71 M. The company has closed loans amounting to ₹62.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Par Formulations Private Limited India is Vineet Kakkad as COMPANY SECRETARY.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111TN1982PTC009602
-
Company No.
009602
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Sep 1982
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Par Formulations Private Limited offer?
Par Formulations Private Limited offers a wide range of products and services, including Osteoporosis Medications, Calcitonin Spray, Antihistamines, Meclizine HCL.
Who are the key members and board of directors at Par Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vineet Kakkad | Company Secretary | 27-May-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
James Papp
|
Director | 28-Jan-2021 | Current |
Chitti Kumar
|
Whole-Time Director | 28-Jun-2017 | Current |
|
Anand Raj
|
Director | 27-May-2022 | Current |
Financial Performance of Par Formulations.
Par Formulations Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 55.06% increase. The company also saw a substantial improvement in profitability, with a 104.06% increase in profit. The company's net worth Soared by an impressive increase of 19.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Par Formulations?
In 2021, Par Formulations had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Par Biosciences Private LimitedChitti Kumar, James Papp and 1 more are mutual person
-
Par Active Technologies Private LimitedChitti Kumar, James Papp and 1 more are mutual person
Charges (Loans)
₹0.17 Cr
₹62.37 Cr
Charges Breakdown by Lending Institutions
- Others : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2022 | Others | ₹1.21 M | Open |
| 08 Aug 2022 | Others | ₹0.50 M | Open |
| 08 Aug 2022 | Others | ₹27.06 Cr | Satisfied |
| 04 Feb 2010 | State Bank Of India | ₹18.00 Cr | Satisfied |
| 06 Mar 2008 | State Bank Of India | ₹15.00 Cr | Satisfied |
How Many Employees Work at Par Formulations?
Par Formulations has a workforce of 1304 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Par Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Par Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
